Aprea Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.996; its P/E ratio is -1.34; Aprea Therapeutics is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.76. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 14.07K	$ 319.47K	-	-	-
Gross Profit	$ 14.07K	$ 319.47K	-	-	-
EBIT	$ -3.44M	$ -3.20M	$ -3.26M	$ -4.38M	$ -2.69M
EBITDA	$ -3.44M	-	$ -3.26M	$ -4.38M	$ -2.69M
Net Income Common Stockholders	$ -3.44M	$ -3.20M	$ -3.26M	$ -4.38M	$ -2.44M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 21.61M	$ 25.35M	$ 27.69M	$ 31.00M	$ 28.79M
Total Assets	$ 22.65M	$ 25.77M	$ 28.68M	$ 32.02M	$ 30.16M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -21.61M	$ -25.35M	$ -27.69M	$ -31.00M	$ -28.79M
Total Liabilities	$ 5.70M	$ 5.48M	$ 5.26M	$ 5.54M	$ 3.20M
Stockholders Equity	$ 16.95M	$ 20.29M	$ 23.42M	$ 26.48M	$ 25.64M
Cash Flow	-
Free Cash Flow	$ -3.75M	-	$ -3.22M	$ -2.98M	$ -4.02M
Operating Cash Flow	$ -3.74M	$ -2.24M	$ -3.22M	$ -2.98M	$ -4.02M
Investing Cash Flow	$ -7.15K	$ -85.94K	-	-	-
Financing Cash Flow	-	-	-	$ 5.14M	$ 98.53K

Currency in USD

Aprea Therapeutics Earnings and Revenue History

Income Statement >

Aprea Therapeutics Debt to Assets

Balance Sheet >

Aprea Therapeutics Cash Flow

Cash Flow >

Aprea Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing